Budget impact of Paxlovid

Published: 9 June 2022| Version 1 | DOI: 10.17632/gvnhbw6m7k.1
Contributor:
Núcleo de Avaliação de Tecnologias em Saúde Instituto Nacional de Cardiologia

Description

Analysis of the Budgetary impact of paxlovid for the treatment of adults who do not require supplemental oxygen and who are at increased risk for progression to severe coronavirus disease 2019 (COVID-19) in Brazil Health System

Files

Institutions

Instituto Nacional de Cardiologia

Categories

Economic Analysis

License